Cancer Cell Clones and Subclones

Cancer Cell Clones and Subclones describe the hierarchical lineage structure within a tumor, in which a clone represents a population of cells descended from a single founding cell and sharing its inherited genetic alterations, while subclones represent further subdivisions arising when additional distinct mutations accumulate in some descendants but not others, producing nested branches of related but genetically distinguishable cell populations.

The Founding Clone

Origin from a Single Transformed Cell

A tumor's founding clone traces back to one original cell that acquired the initial combination of alterations sufficient to begin uncontrolled proliferation, with all subsequent cells in the tumor descending from this single ancestral cell.

Shared Truncal Alterations

Genetic changes present in the founding cell are inherited by every descendant throughout the tumor, forming a set of shared, or truncal, alterations common to the entire cell population regardless of any later divergence.

Formation of Subclones

Branching from the Founding Lineage

As the founding clone expands, individual descendant cells acquire additional mutations independently, and those carrying a shared new alteration form a distinct subclone nested within the broader founding clone.

Nested Hierarchical Structure

Subclones can themselves give rise to further subclones as additional alterations accumulate in some of their descendants, producing a branching, tree-like structure of increasingly specific cell lineages within the tumor.

Nonuniform Distribution Within the Tumor

Because subclones arise from localized expansion of specific descendant lineages, they are often unevenly distributed across different regions of the tumor rather than being mixed uniformly throughout the mass.

Dynamics of Clonal and Subclonal Populations

Competitive Expansion Among Subclones

Different subclones within a tumor can compete for shared local resources and space, with some subclones expanding more successfully than others depending on the relative fitness conferred by their specific combination of alterations.

Fluctuation in Relative Subclone Proportions

The relative abundance of different subclones within a tumor is not necessarily fixed over time, and shifts in local conditions or external pressures can change which subclones make up the larger share of the overall cell population.

Extinction and Persistence of Subclones

Some subclones may decline or disappear over time if they confer no particular advantage or are actively outcompeted, while others persist or expand depending on the conditions they encounter within the tumor.

Detecting and Representing Clonal Structure

Distinguishing Truncal from Branch Alterations

Analysis of a tumor's clonal structure typically distinguishes alterations present in all cells, reflecting the founding clone, from those present only in a subset, reflecting later subclonal branching.

Representing Lineage Relationships

The relationships among a tumor's clone and subclones are often represented as a branching structure, illustrating which subclones share a more recent common origin and which diverged earlier in the tumor's development.

Significance for Tumor Behavior and Treatment

Basis for Intratumoral Heterogeneity

The coexistence of multiple subclones carrying different combinations of alterations is a principal underlying source of the broader phenomenon of intratumoral heterogeneity observed within a single tumor mass.

Implications for Treatment Resistance

Because a treatment targeting a specific alteration may affect some subclones while sparing others lacking that alteration, the presence of multiple subclones creates a pool of variation from which treatment-resistant cell populations can be selected and subsequently expand.

Relevance to Understanding Tumor Progression

Tracking how the relative proportions of clones and subclones shift over the course of a tumor's development provides insight into which lineages are driving continued growth, invasion, or resistance at any given stage.